Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
VENLAFAXINE HYDROCHLORIDE
Medication labelWhy this: Advisory · dailymed-prescription
1.1 Major Depressive Disorder Venlafaxine hydrochloride extended-release capsules, USP are indicated for the treatment of major depressive disorder (MDD). Efficacy was established in three short-term (4, 8, and 12 weeks) and two long-term, maintenance trials. 1.3 Social Anxiety Disorder Venlafaxine hydrochloride extended-release capsules, USP are indicated for the treatment of Social Anxiety Disorder (SAD), also known as social phobia. Efficacy was established in four 12-week and one 26-week, placebo-controlled trials. 1.4 Panic Disorder Venlafaxine hydrochloride extended-release capsules, USP are indicated for the treatment of Panic Disorder (PD), with or without agoraphobia. Efficacy was established in two 12-week placebo-controlled trials.
- generic_name
- venlafaxine hydrochloride
- product_names
- VENLAFAXINE HYDROCHLORIDE
- ndc
- 61919-222, 68382-035, 61919-222-30, 61919-222-60
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en